QuickLinks -- Click here to rapidly navigate through this document

As filed with the Securities and Exchange Commission on May 3, 2006




SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549




SCHEDULE TO
(Rule 14d-100)

Tender Offer Statement
under Section 14(d)(1) of the Securities Exchange Act of 1934
(Amendment No. 7)
Schering Aktiengesellschaft
(Name of Subject Company (issuer))

Dritte BV GmbH
Bayer Aktiengesellschaft
(Name of Filing Persons (offerors))




Ordinary Shares, no par value
(Title of Class of Securities)

DE0007172009
(CUSIP Number of Class of Securities)




American Depositary Shares
(each representing one Ordinary Share)
(Title of Class of Securities)

806585204
(CUSIP Number of Class of Securities)




Dr. Roland Hartwig
Bayerwerk, Gebaeude W11
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
+49 (214) 3081195
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications on Behalf of the Person(s) Filing Statement)

With copies to:

Charles Nathan, Esq.
John E. Sorkin, Esq.
Latham & Watkins LLP
885 Third Avenue
New York, New York 10022
(212) 906-1200
  Dr. Joachim von Falkenhausen
Stefan Widder
Latham & Watkins LLP
Warburgstrasse 50
20354 Hamburg, Germany
+49 (40) 414030





CALCULATION OF FILING FEE



Transaction Valuation*
  Amount of Filing Fee*

$19,860,767,584.80   $2,125,102.13


*
Estimated for purposes of calculating the amount of the filing fee only. The calculation of the transaction valuation assumes the purchase of 191,000,875 bearer shares, no par value per share ("Shares"), of Schering Aktiengesellschaft ("Schering") (including those Shares represented by American Depositary Shares ("ADSs")), at a purchase price of EUR 86.00 per Share in cash, converted into U.S. dollars at the noon buying rate as published by the Federal Reserve Bank of New York on April 10, 2006 of EUR 1 = $1.2091. Such number of Shares represents the number of Shares (including Shares represented by ADSs) issued and outstanding as of April 11, 2006 and excludes Shares held by Schering in treasury.

ý
Check the box if any part of the filing fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
Amount Previously Paid:   $2,125,102.13
Form or Registration No.:   Schedule TO
Filing Party:    
    Dritte BV GmbH
    Bayer Aktiengesellschaft
Date Filed:   April 13, 2006
o
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transaction to which the statement relates:

ý
third-party tender offer subject to Rule 14d-1.

o
issuer tender offer subject to Rule 13e-4.

o
going-private transaction subject to Rule 13e-3.

o
amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer:    o


        This Amendment No. 7 to Schedule TO (this "Amendment") amends and supplements the Tender Offer Statement on Schedule TO, as amended through the date hereof (as amended, the "Statement"), originally filed with the Securities and Exchange Commission (the "SEC") on April 13, 2006 by Dritte BV GmbH, a limited liability company organized under the laws of the Federal Republic of Germany (the "Bidder") and a wholly-owned subsidiary of Bayer Aktiengesellschaft, a stock corporation organized under the laws of the Federal Republic of Germany ("Bayer AG"), and Bayer AG, relating to a tender offer by the Bidder to purchase all of the issued and outstanding bearer shares, with no par value (the "Shares"), including those Shares represented by American Depositary Shares ("ADSs"), of Schering Aktiengesellschaft, a stock corporation organized under the laws of the Federal Republic of Germany ("Schering"), at a purchase price of EUR 86.00 per Share in cash. The terms and conditions of the offer (as it may be amended or supplemented from time to time, the "Offer") are described in the Offer Document, published on April 13, 2006 (the "Offer Document"), a copy of which was originally filed as Exhibit (a)(1)(A), and, where applicable, the related U.S. Declaration of Acceptance and ADS Letter of Transmittal and the instructions thereto, copies of which were originally filed as Exhibits (a)(1)(B) and (C), to the Statement. Except as otherwise indicated, the information set forth in the Statement remains unchanged. Capitalized terms used but not defined herein have the meanings ascribed to them in the Statement.

Additional Disclosure and Amendments to the Offer Document

        Items 1 through 11 of the Statement, to the extent such Items incorporate by reference the information contained in the Offer Document, are hereby amended and supplemented as follows:

1.
Section 1.1 of the Offer Document, entitled "General Information and Information for Shareholders with Place of Residence, Seat or Habitual Abode Outside the Federal Republic of Germany—Performance of the Voluntary Offer in Accordance with the Provisions of the German Securities and Takeover Act and the Securities Laws of the U.S.A.", is hereby amended and supplemented by adding the following to the end of the fifth paragraph thereof on page 4 of the Offer Document:

2


2.
Section 2 of the Offer Document, entitled "Summary of the Offer", is hereby amended and supplemented by adding the following after the section entitled "Additional Acceptance Period" on page 8 of the Offer Document:

"Withdrawal Rights:   Schering Securityholders who accept the Offer during the Acceptance Period may withdraw their declared acceptance at any time until the expiration of the Acceptance Period, including in the event of an amendment to the terms of the Offer or if there is a competing offer.

 

 

If all of the Offer Conditions have been satisfied or, if permissible, waived by the expiration of the Acceptance Period (except that the Bidder has not yet determined whether the Minimum Acceptance Threshold (as defined in Section 6.1.1) has been met), Schering Securityholders will not have the right to withdraw their acceptance of the Offer during the period of up to eight Banking Days following the expiration of the Acceptance Period to permit the Bidder to determine whether the Minimum Acceptance Threshold has been met and to pay for the tendered Schering Securities.

 

 

If all of the Offer Conditions, other than the Offer Condition relating to receipt of regulatory approvals stated in Section 6.1.2, have been satisfied or, if permissible, waived by the expiration of the Acceptance Period (except that the Bidder has not yet determined whether the Minimum Acceptance Threshold has been met), then Schering Securityholders will not have the right to withdraw their acceptance of the Offer unless the Offer Condition stated in Section 6.1.2 has not been satisfied by the end of the 21stcalendar day from the expiration of the Acceptance Period, in which case withdrawal rights will be restored. However, if withdrawal rights are restored as described in the preceding sentence, Schering Securityholders will not have the right to withdraw their acceptance of the Offer following the satisfaction of the condition stated in Section 6.1.2 to permit the Bidder to make payment for the Schering Shares;
provided, that such payment is made within eight Banking Days of the satisfaction of such condition.

 

 

It is possible that the Bidder will request from the Staff of the SEC an extension of the 21-day period described above. If an extension is granted, the Bidder will make an announcement prior to the expiration of the 21-day period in accordance with Section 18.

 

 

See Section 14 for a description of the withdrawal rights applicable to the Offer.
     

3



Settlement:

 

If the Offer Conditions have been fulfilled by the end of the Acceptance Period or, if permissible, waived, payment of the Offer Price will be made no earlier than the fourth, but no later than the eighth, Banking Day after the expiration of the Acceptance Period. In the event that the Offer Conditions are not fulfilled until after the expiration of the Acceptance Period, payment of the Offer Price will be made no earlier than the fourth, but no later than the eighth, Banking Day after the date on which the Bidder announces the satisfaction of the last Offer Condition in accordance with Section 6.4.

 

 

Payment for Schering Securities for which the Offer is accepted during the Additional Acceptance Period will be made no earlier than the fourth, but no later than the eighth, Banking Day after the expiration of the Additional Acceptance Period;
provided, that if the Offer Conditions are not fulfilled until after the expiration of the Additional Acceptance Period, payment of the Offer Price will be made no earlier than the fourth, but no later than the eighth, Banking Day after the date on which the Bidder announces the satisfaction of the last Offer Condition in accordance with Section 6.4.

 

 

See Sections 5.1.5, 5.1.6 and 5.2.7 for a more detailed description of the settlement and payment procedures for the Offer.

Plans and Intentions of the Bidder:

 


Following the consummation of the Offer, the Bidder and Bayer AG intend to enter into a domination and profit and loss transfer agreement with the Bidder as the "controlling company" and Schering AG as the "controlled company". Entering into a domination and profit and loss transfer agreement requires, among other things, the consent of at least 75% of the represented share capital at a general shareholders' meeting of Schering AG and would result in the requirement that the Bidder make a recurring cash payment as compensation to any remaining minority shareholders. In addition, the Bidder would be obligated to make a mandatory offer to acquire all outstanding Schering Securities belonging to minority shareholders in exchange for a payment of fair cash compensation determined in accordance with German law. See Section 10.2.5 for a more detailed description of the domination and profit and loss transfer agreement, the calculation of the recurring cash payment and the determination of the fair cash compensation to be offered in the related mandatory offer.
     

4



 

 

Depending on the level of acceptance of the Offer, the Bidder and Bayer AG might consider causing Schering AG to apply for a revocation of the admission of the Schering Shares on the German stock exchanges where they are traded. The Bidder and Bayer AG intend to cause Schering AG to apply for a revocation of the admission of the Schering Shares on the Swiss stock exchange. In addition, the Bidder and Bayer AG intend to cause Schering AG to delist the Schering ADSs from the New York Stock Exchange and, if permitted, to terminate the registration of the Schering Securities under the Exchange Act (in which case Schering AG would no longer be required to file announcements or reports with the SEC). See Section 10.2.5.

 

 

If, following consummation of the Offer or at a later point in time the Bidder owns 95% or more of the share capital of Schering AG, the Bidder and Bayer AG intend to bring about the adoption of a resolution by the general shareholders' meeting of Schering AG effecting a squeeze-out, or transfer of the Schering Shares held by the minority shareholders to the Bidder, in exchange for fair cash compensation in accordance with German law. Upon completion of the squeeze-out, the stock exchange listings of the Schering Shares and Schering ADSs, and the registration of the Schering Securities under the Exchange Act, to the extent not previously terminated, would be terminated. See Section 10.2.5 for a more detailed description of the squeeze-out procedure and the determination of the fair cash compensation to be paid."
3.
Section 4.3 of the Offer Document, entitled "Acceptance Period—Additional Acceptance Period Pursuant to Section 16(2) of the WpÜG", is hereby amended and supplemented by adding the following to the end of the first paragraph thereof on page 14 of the Offer Document:
4.
Section 5.1.4 of the Offer Document, entitled "Acceptance and Settlement of the Offer for Schering Securities—Acceptance and Settlement of the Offer for Schering Shares—Legal Consequences of the Acceptance", is hereby amended and supplemented by adding the following to the end of the first paragraph thereof on page 16 of the Offer Document:

5


5.
Section 5.1.10 of the Offer Document, entitled "Acceptance and Settlement of the Offer for Schering Securities—Acceptance and Settlement of the Offer for Schering Shares—Right of Withdrawal", is hereby amended and supplemented by adding the following after the first paragraph thereof on page 17 of the Offer Document:

6


6.
Section 5.2.4 of the Offer Document, entitled "Acceptance and Settlement of the Offer for Schering Securities—Acceptance by Schering Shareholders Resident in the U.S.A. and Schering ADS Holders and Settlement of the Offer—Legal Consequences of the Acceptance", is hereby amended and supplemented by adding the following to the end of the first paragraph thereof on page 22 of the Offer Document:
7.
Section 5.2.10 of the Offer Document, entitled "Acceptance and Settlement of the Offer for Schering Securities—Acceptance by Schering Shareholders Resident in the U.S.A. and Schering ADS Holders and Settlement of the Offer—Right of Withdrawal", is hereby amended and supplemented by adding the following after the first paragraph thereof on page 23 of the Offer Document:

7


8.
Section 6.2 of the Offer Document, entitled "Conditions of the Offer—Waiver of the Conditions", is hereby amended and supplemented by adding the following to the end of the first paragraph thereof on page 25 of the Offer Document:
9.
Section 8.1 of the Offer Document, entitled "The Bidder/Bayer AG—Description of the Bidder", is hereby amended and supplemented by adding the following to the end thereof, which information updates the information contained in the last paragraph of such section on page 28 of the Offer Document:
10.
Section 8.2.1 of the Offer Document, entitled "The Bidder/Bayer AG—Description of Bayer AG and the Bayer Group—Bayer AG", is hereby amended and supplemented by adding the following to the end thereof, which information updates the information contained in the last paragraph of such section on page 31 of the Offer Document:
11.
Section 8.6 of the Offer Document, entitled "The Bidder/Bayer AG—Schering Shares Held by Managing Directors, Management Board Members, and Supervisory Board Members", is hereby

8


12.
Section 10.2.5(iii) of the Offer Document, entitled "Background of the Offer/Intentions of the Bidder and Bayer AG with Regard to Schering AG—Intentions of the Bidder and Bayer AG with Regard to Schering AG—Possible Structural Measures—Exclusion of Minority Shareholders ("Squeeze-out")", is hereby amended and supplemented by adding the following as a new second paragraph thereof on page 38 of the Offer Document:
13.
Section 10.2.5 of the Offer Document, entitled "Background of the Offer/Intentions of the Bidder and Bayer AG with Regard to Schering AG—Intentions of the Bidder and Bayer AG with Regard to Schering AG—Possible Structural Measures", is hereby amended and supplemented by adding the following as a new clause (v) thereof on page 38 of the Offer Document:

9


14.
Section 11.2.1 of the Offer Document, entitled "Financing the Offer—Bridge Financing", is hereby amended and supplemented by adding the following to the end of the fourth paragraph thereof on page 39 of the Offer Document:
15.
Section 11.2.4 of the Offer Document, entitled "Financing the Offer—Debt Commitments", is hereby amended and supplemented by adding the following to the end of the fourth paragraph thereof on page 40 of the Offer Document:

10


16.
Section 13 of the Offer Document, entitled "Possible Effects on Schering Securityholders Who Do Not Accept the Offer", is hereby amended and supplemented by adding the following after the second sub-bullet point of the first bullet point on page 44 of the Offer Document:

    "•
    the Bidder and Bayer AG currently intend to cause Schering AG to apply for a revocation of the listing of the Schering ADSs on the NYSE (in case of delisting on the NYSE, Schering ADSs would also lose their classification as "margin securities" under the margin regulations in which case they could no longer serve as security for loans) and a delisting of the Schering Shares from the Swiss stock exchange and will consider seeking the revocation of admission of the Schering Shares to the German stock exchanges (delisting). The delisting or revocation of admission of the Schering ADSs and the Schering Shares would each require the cooperation of Schering AG. The Bidder would have no assurance of such cooperation until the implementation of a domination agreement as discussed above. Nonetheless, the Bidder intends to seek such cooperation from Schering AG before such time, at least with respect to a delisting from the NYSE and the Swiss stock exchange. If such cooperation were forthcoming, it is possible that such delisting could be implemented within a few months from the consummation of this Offer; and"

17.
Section 14.1 of the Offer Document, entitled "Rights Of Withdrawal—Right to Withdraw without Giving Reasons" is hereby amended and supplemented by adding the following new paragraph to the end thereof:
18.
Section 16.2 of the Offer Document, entitled "Taxes—Certain U.S. Federal Income Tax Consequences of the Sale of Schering Shares or Schering ADSs", is hereby amended and supplemented by adding the following after the first sentence of the first paragraph of such section on page 47 of the Offer Document:

11


19.
Section 16.2 of the Offer Document, entitled "Taxes—Certain U.S. Federal Income Tax Consequences of the Sale of Schering Shares or Schering ADSs", is hereby amended and supplemented by adding the following to the end of the existing second sentence of the first paragraph of such section on page 47 of the Offer Document:
20.
Section 17.1 of the Offer Document, entitled "Relief Requested from the SEC—Stated Relief to Reconcile Conflicts between Jurisdictions", is hereby amended and supplemented by adding the following sentence to the end of the second paragraph thereof at the top of page 49 of the Offer Document (the first paragraph on page 49 of the Offer Document):
21.
Section 20 of the Offer Document, entitled "Applicable Law", is hereby amended and supplemented by adding the following to the end of the first paragraph thereof on page 50 of the Offer Document:

12


Additional Exhibits

Item 12 of the Statement is hereby amended and supplemented by adding the following exhibit thereto, which exhibit is filed as part of this Amendment:

(a)(5)(M)   Press Conference Call Transcript, dated March 24, 2006 (this exhibit is being refilled to include certain charts that were omitted from the version filed as Exhibit 99.8 to the Schedule TO-C filed by the Bidder and Bayer AG on March 24, 2006. The information contained in the charts was included in the charts filed as Exhibits 99.1 and 99.2 to the Schedule TO-C filed by the Bidder and Bayer AG on March 24, 2006.)

13



SIGNATURE

        After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

        Dated: May 3, 2006

    Bayer Aktiengesellschaft

 

 

By:

/s/  
DR. ROLAND HARTWIG      
Name:  Dr. Roland Hartwig
Title:    General Counsel

 

 

By:

/s/  
DR. ALEXANDER ROSAR      
Name:  Dr. Alexander Rosar
Title:    Head of Investor Relations

 

 

Dritte BV GmbH

 

 

By:

/s/  
DR. ARMIN BUCHMEIER      
Name:  Dr. Armin Buchmeier
Title:    Managing Director

14




QuickLinks

SIGNATURE